Biology Reference
In-Depth Information
[79] Miretti MM, Walsh EC, Ke X, Delgado M, Griffths M, Hunt S, et al. A high-resolution
linkage-disequilibrium map of the human major histocompatibility complex and first
generation of tag single-nucleotide polymorphisms. Am J Hum Genet 2005;76:634-6.
[80] Dawkins R, Leelayuwat C, Gaudieri S, Tay G, Hui J, Cattley S, et al. Genomics of the
major histocompatibility complex: haplotypes, duplication, retroviruses and disease
(Review). Immunol Rev 1999;167:275-304.
[81] De Bakker PI, McVean G, Sabeti PC, Miretti MM, Green T, Marchini J, et al. A high-
resolution HLA and SNP haplotype map for disease association studies in the extended
human MHC. Nat Genet 2006;38:1166-72.
[82] Ahmad T, Neville M, Marshall SE, Armuzzi A, Mulcahy-Hawes K, Crawshaw J, et al.
Haplotype-specific linkage disequilibrium patterns define the genetic topography of
the human MHC. Hum Mol Genet 2003;12:647-56.
[83] Allcock RJ, Atrazhev AM, Beck S, de Jong PJ, Elliott JF, Forbes S, et al. The MHC
haplotype project: a resource for HLA-linked association studies. Tissue Antigens
2002;59:520-1.
[84] Baschal EE, Aly TA, Jasinski JM, Steck AK, Noble JA, Erlich HA, et al. Type 1 Diabetes
Genetics Consortium. Defining multiple common “completely” conserved major
histocompatibility complex SNP haplotypes. Clin Immunol 2009;132:203-14.
[85] Smith WP, Vu Q, Li SS, Hansen JA, Zhao LP, Geraghty DE. Toward understanding MHC
disease associations: partial resequencing of 46 distinct HLA haplotypes. Genomics
2006;87:561-71.
[86] Walsh EC, Mather KA, Schaffner SF, Farwell L, Daly MJ, Patterson N, et al. An integrated
haplotype map of the human major histocompatibility complex. Am J Hum Genet
2003;73:580-90.
[87] Jeffreys AJ, Kauppi L, Neumann R. Intensely punctate meiotic recombination in the
class II region of the major histocompatibility complex. Nat Genet 2001;29:217-22.
[88] Ketheesan N, Gaudieri S, Witt CS, Tay GK, Townend DC, Christiansen FT, et al. Recon-
struction of the block matching profiles. Hum Immunol 1999;60:171-6.
[89] Tay GK, Witt CS, Christiansen FT, Charron D, Baker D, Herrmann R, et al. Matching for
MHC haplotypes results in improved survival following unrelated bone marrow trans-
plantation. Bone Marrow Transplant 1995;15:381-5.
[90] Guo Z, Hood L, Malkki M, Petersdorf EW. Long-range multilocus haplotype phasing of
the MHC [erratum appears in Proc Natl Acad Sci USA. 2006 Jun 13;103(24):9374]. Proc
Natl Acad Sci USA 2006;103:6964-9.
[91] Petersdorf EW, Malkki M, Gooley TA, Martin PJ, Guo Z. MHC haplotype matching for
unrelated hematopoietic cell transplantation. PLoS Med 2007;4:e8.
[92] Malkki M, Gooley TA, Horowitz MM, Absi L, Christiansen FT, Cornelisseen JJ,
et al. International Histocompatibility Working Group in Transplantation. Map-
ping MHC-resident transplantation determinants. Biol Blood Marrow Transplant
2007;13:986-95.
[93] Li S, Kawata H, Katsuyama Y, Ota M, Morishima Y, Mano S, et al. Association of poly-
morphic MHC microsatellites with GVHD, survival, and leukemia relapse in unrelated
hematopoietic stem cell transplant donor/recipient pairs matched at five HLA loci.
Tissue Antigens 2004;63:362-8.
[94] The Human Genome Project - Welcome Trust. Sanger Institute.
http://www.sanger.ac.
[95] Morishima S, Ogawa S, Matsubura A, Kawase T, Nannya Y, Kashiwase K, et al. Japan
Marrow Donor Program. Impact of highly conserved HLA haplotype on acute graft-
versus-host disease. Blood 2010;115:4664-70.
[96] Charron DJ. HLA matching in unrelated donor bone marrow transplantation. Curr
Opin Hematol 1996;3:416-22.
[97] Tamouza R, Busson M, Rocha V, Fortier C, Haddad Y, Brun M, et al. Homozygous status
for HLA-E*0103 confers protection from acute graft-versus-host disease and trans-
plant-related mortality in HLA-matched sibling hematopoietic stem cell transplanta-
tion. Transplantation 2006;82:1436-40.
[98] Hosseini E, Schwarer AP, Ghasemzadeh M. The Impact of HLA-E Polymorphisms in
graft-versus-host disease following HLA-E matched allogeneic hematopoietic stem cell
transplantation. Iran J Allergy Asthma Immunol 2012;11:15-21.
[99] Danzer M, Polin H, Pröll J, Haunschmid R, Hofer K, Stabentheiner S, et al. Clinical
significance of HLA-E*0103 homozygosity on survival after allogeneic hematopoietic
stem-cell transplantation. Transplantation 2009;27(88):528-32.
[100] Ludajic K, Rosenmayr A, Faé I, Fischer GF, Balavarca Y, Bickeböller H, et al. Association
of HLA-E polymorphism with the outcome of hematopoietic stem-cell transplantation
with unrelated donors. Transplantation 2009;88:1227-8.
[101] Furst D, Bindja J, Arnold R, Herr W, Schwerdtfeger R, Müller CH, et al. HLA-E polymor-
phisms in hematopoietic stem cell transplantation. Tissue Antigens 2012;79:287-90.
37
Search WWH ::
Custom Search